Breaking News

Dow Offers New Technology to Solve Pharma Challenges

Company’s silicone chemistries target cost control, product differentiation and solubility challenges

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dow Food, Pharma & Medical, a business unit of The Dow Chemical Company, has enhanced its ability to assist pharmaceutical customers in addressing macro trends such as potential drug pricing restrictions, product differentiation and delivery of new therapies through improved active pharmaceutical ingredient (API) solubility. The company has also expanded its portfolio of pharmaceutical, healthcare technologies and formulation support, stemming largely from Dow’s 2016 acquisition of Dow Corni...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters